Windtree Therapeutics, a Nasdaq-listed company, has announced plans to buy $60 million BNB as part of its push for a cryptocurrency treasury strategy. The company announced on July 16 that it had entered into a securities purchase agreement for $60…
Related Posts
Brahma turns DeFi collateral into real-world spending power in Euler Labs tie-up
Brahma’s partnership with Euler Labs introduces a credit card that taps directly into DeFi collateral, letting users spend…
HIP-3 Explosion: The Feature Driving HYPE’s Double-Digit Surge
Hyperliquid’s token HYPE has surged 23% over the past 24 hours, pushing the price action into a zone…
Arthur Hayes says macro setup favours Bitcoin bulls as KangaMoon attracts investors
Arthur Hayes is bullish on crypto amid the macro setup that he says could present a golden opportnity…